Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Balázs Győrffy"'
Autor:
Csaba Miskey, Lacramioara Botezatu, Nuri A. Temiz, Andreas Gogol-Döring, Áron Bartha, Balázs Győrffy, David A. Largaespada, Zoltán Ivics, Attila Sebe
Publikováno v:
Molecular Cancer Research. 20:1502-1515
Metastasis, a complex, multistep process, is responsible for the overwhelming majority of cancer-related deaths. Despite its devastating consequences, it is not possible to effectively treat cancer that has spread to vital organs, the mechanisms lead
Autor:
Crismita Dmello, Aarón Sonabend, Victor A. Arrieta, Daniel Y. Zhang, Deepak Kanojia, Li Chen, Andrew Gould, Jiangshan Zhang, Seong Jae Kang, Jan Winter, Craig Horbinski, Christina Amidei, Balázs Győrffy, Alex Cordero, Catalina Lee Chang, Brandyn Castro, Patrick Hsu, Atique U. Ahmed, Maciej S. Lesniak, Roger Stupp, Adam M. Sonabend
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 28, iss 14
Clin Cancer Res
Clin Cancer Res
Purpose: Paclitaxel (PTX) is one of the most potent and commonly used chemotherapies for breast and pancreatic cancer. Several ongoing clinical trials are investigating means of enhancing delivery of PTX across the blood–brain barrier for glioblast
Autor:
Xiaokai Ding, Amanda C. Sharko, Martina S. J. McDermott, Gary P. Schools, Alexander Chumanevich, Hao Ji, Jing Li, Li Zhang, Zachary T. Mack, Vitali Sikirzhytski, Michael Shtutman, Laura Ivers, Norma O’Donovan, John Crown, Balázs Győrffy, Mengqian Chen, Igor B. Roninson, Eugenia V. Broude
Publikováno v:
Proceedings of the National Academy of Sciences. 119
Breast cancers (BrCas) that overexpress oncogenic tyrosine kinase receptor HER2 are treated with HER2-targeting antibodies (such as trastuzumab) or small-molecule kinase inhibitors (such as lapatinib). However, most patients with metastatic HER2+BrCa
Autor:
Iris Kahl, Julian Mense, Christopher Finke, Anna‐Lena Boller, Clara Lorber, Balázs Győrffy, Burkhard Greve, Martin Götte, Nancy A Espinoza‐Sánchez
Publikováno v:
Journal of cellular biochemistryREFERENCES. 123(3)
Breast cancer is the third most common type of cancer diagnosed. Cell cycle is a complex but highly organized and controlled process, in which normal cells sense mitogenic growth signals that instruct them to enter and progress through their cell cyc
Autor:
Kei-ichiro Arimoto, Leo J.Y. Kim, Balázs Győrffy, Klaus-Peter Knobeloch, Dong-Er Zhang, Hua Cheng, Christoph Burkart, Xiang-Dong Fu, Jeremy N. Rich, Hu Cang, Jun-Bao Fan, Yu Zhou, Hui-Zhong Xu, Ming Yan, Sayuri Miyauchi, Dan Liu
Publikováno v:
Cancer Discov
Type I interferons (IFN), which activate many IFN-stimulated genes (ISG), are known to regulate tumorigenesis. However, little is known regarding how various ISGs coordinate with one another in developing antitumor effects. Here, we report that the I
Autor:
János Tibor Fekete, Balázs Győrffy
Publikováno v:
International Journal of Cancer. 145:3140-3151
Systemic therapy of breast cancer can include chemotherapy, hormonal therapy and targeted therapy. Prognostic biomarkers are able to predict survival and predictive biomarkers are able to predict therapy response. In this report, we describe the init
Autor:
Cinzia Giordano, Ines Barone, Valentina Vircillo, Daniela Bonofiglio, Balázs Győrffy, Luca Gelsomino, Roberta Tarallo, Giuseppina Bruno, Francesco Romeo, Sebastiano Andò, Antonella Caruso, Antonio Rinaldi, Stefania Catalano
Publikováno v:
Cancer Letters. 437:89-99
Cancer-associated Fibroblasts (CAFs), the principal components of tumor microenvironment, play multiple role in breast cancer progression. We have previously shown an oncosuppressive role of the nuclear Farnesoid X Receptor (FXR) in mammary epithelia
Autor:
Angel L. Corbí, Mariona Baliu-Piqué, María Del Mar Noblejas-López, Cristina Nieto-Jiménez, Esther Cabañas Morafraile, Atanasio Pandiella, Balázs Győrffy, Francisco J. Cimas, Alberto Ocaña
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
International Journal of Molecular Sciences, Vol 22, Iss 3836, p 3836 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 8
instname
International Journal of Molecular Sciences, Vol 22, Iss 3836, p 3836 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 8
© 2021 by the authors.
Targeting the innate immune system has attracted attention with the development of anti- CD47 antibodies. Anti-CD47 antibodies block the inhibition of the phagocytic activity of macrophages caused by the up-regulation of
Targeting the innate immune system has attracted attention with the development of anti- CD47 antibodies. Anti-CD47 antibodies block the inhibition of the phagocytic activity of macrophages caused by the up-regulation of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7ce0a39bd01c9b4d774ba4e6f13164b
http://hdl.handle.net/10261/262385
http://hdl.handle.net/10261/262385
Autor:
Ludwig Kiesel, Mauro S. G. Pavão, Burkhard Greve, Nancy Adriana Espinoza-Sánchez, Balázs Győrffy, Julia Kuehn, Felipe C O B Teixeira, Martin Götte
Publikováno v:
Journal of cellular biochemistryREFERENCES. 122(5)
Breast cancer continues to be a serious public health problem. The role of the hedgehog pathway in normal development of the mammary gland as well as in carcinogenesis and progression of breast cancer is the subject of intense investigation, revealin
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Purpose Dysregulated expression of proteoglycans influences the outcome and progression of numerous cancers. Several studies have investigated the role of individual glypicans in cancer, however, the impact of the whole glypican family of heparan sul